These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12748436)

  • 1. Attitudes towards genetic screening for predisposition to colon cancer among cancer patients, their relatives and members of the community. Results of focus group interviews.
    Ramsey SD; Wilson S; Spencer A; Geidzinska A; Newcomb P
    Community Genet; 2003; 6(1):29-36. PubMed ID: 12748436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer.
    Manne SL; Chung DC; Weinberg DS; Vig HS; Catts Z; Cabral MK; Shannon K; Meropol NJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2110-7. PubMed ID: 17932359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing for colorectal carcinoma susceptibility: focus group responses of individuals with colorectal carcinoma and first-degree relatives.
    Kinney AY; DeVellis BM; Skrzynia C; Millikan R
    Cancer; 2001 Jan; 91(1):57-65. PubMed ID: 11148560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of genetic testing for colorectal cancer susceptibility.
    Solomon CH; Pho LN; Burt RW
    Oncology (Williston Park); 2002 Feb; 16(2):161-71; discussion 176, 179-80. PubMed ID: 11866134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning.
    Esplen MJ; Madlensky L; Aronson M; Rothenmund H; Gallinger S; Butler K; Toner B; Wong J; Manno M; McLaughlin J
    Clin Genet; 2007 Nov; 72(5):394-401. PubMed ID: 17892499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of genetic testing for cancer predisposition among Ashkenazi Jewish women.
    Lewis MJ; Peterson SK
    Community Genet; 2007; 10(2):72-81. PubMed ID: 17380056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward colon cancer gene testing: factors predicting test uptake.
    Codori AM; Petersen GM; Miglioretti DL; Larkin EK; Bushey MT; Young C; Brensinger JD; Johnson K; Bacon JA; Booker SV
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):345-51. PubMed ID: 10207639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interest in genetic testing among first-degree relatives of colorectal cancer patients.
    Kinney AY; Choi YA; DeVellis B; Kobetz E; Millikan RC; Sandler RS
    Am J Prev Med; 2000 Apr; 18(3):249-52. PubMed ID: 10722992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
    McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
    Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
    Petersen GM; Larkin E; Codori AM; Wang CY; Booker SV; Bacon J; Giardiello FM; Boyd PA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):337-44. PubMed ID: 10207638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticipated uptake of genetic testing for familial melanoma in an Australian sample: An exploratory study.
    Kasparian NA; Meiser B; Butow PN; Soames Job RF; Mann GJ
    Psychooncology; 2007 Jan; 16(1):69-78. PubMed ID: 16874747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes toward genetic testing in patients with colorectal cancer.
    Kinney AY; Choi YA; DeVellis B; Millikan R; Kobetz E; Sandler RS
    Cancer Pract; 2000; 8(4):178-86. PubMed ID: 11898257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary melanoma and predictive genetic testing: why not?
    Riedijk SR; de Snoo FA; van Dijk S; Bergman W; van Haeringen A; Silberg S; van Elderen TM; Tibben A
    Psychooncology; 2005 Sep; 14(9):738-45. PubMed ID: 15744786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing for inflammatory bowel disease: focus group analysis of patients and family members.
    Lewis JR; Konda V; Rubin DT
    Genet Test Mol Biomarkers; 2009 Aug; 13(4):495-503. PubMed ID: 19580441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to undergo colorectal cancer screening in first-degree relatives of hospitalized patients with colorectal cancer.
    Delgado-Plasencia L; López-Tomassetti-Fernández E; Hernández-Morales A; Torres-Monzón E; González-Hermoso F
    J Med Screen; 2009; 16(1):33-8. PubMed ID: 19349529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
    Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Family-based screening for colorectal cancer: The Australian perspective.
    Leggett BA
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S29-32. PubMed ID: 19799695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.